Cadence Capital Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-39,692
Closed -$3.15M – 620
2015
Q4
$3.15M Sell
39,692
-1,224
-3% -$85.7K 0.21% 127
2015
Q3
$2.4M Sell
40,916
-39,513
-49% -$2.61M 0.17% 151
2015
Q2
$5.17M Buy
80,429
+74,440
+1,243% +$4.56M 0.29% 88
2015
Q1
$365K Sell
5,989
-7,031
-54% -$480K 0.02% 537
2014
Q4
$762K Buy
+13,020
New +$663K 0.04% 450
2014
Q3
– Sell
-81,610
Closed -$4.11M – 544
2014
Q2
$4.11M Buy
+81,610
New +$3.76M 0.2% 203
2014
Q1
– Sell
-92,110
Closed -$3.75M – 587
2013
Q4
$3.75M Buy
+92,110
New +$3.4M 0.14% 281
2013
Q3
– Sell
-30,000
Closed -$860K – 605
2013
Q2
$860K Buy
+30,000
New +$874K 0.04% 323

Other funds holding ALKS

Cadence Capital Management's ALKS Position: Q1 2016 in Review

Cadence Capital Management sold out of Alkermes (ALKS) in Q1 2016, closing a stake of 39,692 shares — an estimated $3.15M sold.

Cadence Capital Management first reported a position in ALKS in Q2 2013 and held it in 8 quarters. The position peaked at $5.17M in Q2 2015. 243 funds tracked by Wall St. Rank hold ALKS as of Q1 2016.

  • Cadence Capital Management reported no remaining Alkermes position as of Q1 2016 after selling out during the quarter.
  • Cadence Capital Management sold 39,692 Alkermes shares in Q1 2016, an estimated $3.15M.
  • Cadence Capital Management first reported a position in Alkermes in Q2 2013 and held it in 8 quarters.
  • Cadence Capital Management's Alkermes position peaked at $5.17M in Q2 2015.
  • 243 funds tracked by Wall St. Rank held Alkermes as of Q1 2016.

Based on Cadence Capital Management's 13F filing for Q1 2016, filed 2 May 2016.